M
Michael Smerina
Researcher at Mayo Clinic
Publications - 4
Citations - 27
Michael Smerina is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 2 publications receiving 17 citations.
Papers
More filters
Journal ArticleDOI
Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019.
Megan Melody,Jared Nelson,Jacquelyn Hastings,Joshua Propst,Michael Smerina,Julio C. Mendez,Pramod Guru +6 more
TL;DR: A 68-year-old man with COVID-19 who was initially treated with hydroxychloroquine and lenzilumab but continued to develop hypoxemia was treated with tocilizumab with marked clinical improvement and a decrease in acute phase reactants within 48 h.
Journal ArticleDOI
Characteristics, Treatment Patterns, and Clinical Outcomes After Heart Failure Hospitalizations in COVID-19 Pandemic, March – October 2020
Mohammed Yousufuddin,Mohamad H. Yamani,Kianoush Kashani,Ye Zhu,Zhen Wang,Ashok Seshadri,K. Blocker,Jessica Peters,Jewell M. Doss,Dhauna Karam,Kanika Khandelwal,U. M. Sharma,Daniel V. Dudenkov,Tahir Mehmood,Sandeep R. Pagali,Sanjeev Nanda,Ahmed D. Abdalrhim,Nichole Cummings,Sagar Dugani,Michael Smerina,Larry J. Prokop,Lawrence Keenan,Sumit Bhagra,Arshad Jahangir,Philippe R. Bauer,Gregg C. Fonarow,M. Hassan Murad +26 more
TL;DR: In this paper , the authors compared clinical characteristics, treatment patterns, and 30-day all-cause readmission and mortality between patients hospitalized for heart failure (HF) before and during the coronavirus disease 2019 (COVID-19) pandemic.
Journal ArticleDOI
The Dynamics of SARS-CoV-2 (RT-PCR) Testing
TL;DR: In this article, the authors present three challenging cases requiring cautious interpretation of the newest generation of RT-PCR molecular detection assays, highlighting the major challenges faced by providers treating patients potentially infected with SARS-CoV-2.
Journal ArticleDOI
Acute Onset of Heart Failure and Renal Failure Due to Pacemaker Syndrome
TL;DR: In this article , the authors report the outcome of an 87-year-old man with permanent nonvalvular atrial fibrillation who initially presented with complete heart block and received a single right ventricle lead pacemaker programmed to ventricular demand pacing.